Postanesthesia Care

Latest Issue of OR Manager
January 2025
Home Postanesthesia Care

Health systems add additional training, educational resources for nursing, perioperative staff

Editor's Note Training and retention of staff is a top priority among healthcare leaders today, as increased healthcare demand and staff shortages continue to affect facilities across the country. Most recently, Geisinger, as well as Lutheran Medical Center and  Houston Methodist Hospital have introduced and expanded educational and cross-training programs…

Read More

By: Lindsay Botts
April 20, 2023
Share

Researchers affirm airborne spread of COVID-19

Editor's Note In this study, Canadian researchers succeeded in isolating infectious particles of the COVID-19 virus from air samples collected from hospital rooms. A total of 30 samples were collected from 10 different rooms of patients with COVID-19 and then frozen in a biobank for 14 months. The researchers were…

Read More

By: Judy Mathias
April 20, 2023
Share

Effect of nurse staffing level, length of work experience on HAIs

Editor's Note This study from Finland examines the associations between nurse understaffing and limited work experience on the risk of healthcare-associated infections (HAIs). Patient and staff data from 40 care units and 261,067 admissions in one hospital district in Finland were analyzed. The researchers found that 1- or 2-day exposure…

Read More

By: Judy Mathias
April 19, 2023
Share

ACS releases new breast cancer standards

Editor's Note The American College of Surgeons (ACS) National Accreditation Program for Breast Centers (NAPBC), on April 19, released new breast cancer standards that put the individualized needs of the patients first and focus on shared decision-making. Previous standards addressed surgical care issues through an interdisciplinary lens, but they were…

Read More

By: Judy Mathias
April 19, 2023
Share

Sponsored Message

FDA: Class I recall of Ivenix Infusion System

Editor's Note The Food and Drug Administration (FDA), on April 19, identified the recall by Fresenius Kabi USA of its Ivenix Infusion System as Class I, the most serious. The recall was initiated because of a leak in the system that allows fluid to enter the administration set loading area…

Read More

By: Judy Mathias
April 19, 2023
Share

FDA updates opioid prescribing information

Editor's Note The Food and Drug Administration (FDA), on April 13, updated prescribing information for all opioid pain medications, including requiring all packaging to have updated labeling and safety information. This includes stating that: for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medications, the risk of overdose…

Read More

By: Judy Mathias
April 18, 2023
Share

Sponsored Message

FDA issues Safety Communication on certain N95 respirators, surgical masks

Editor's Note The Food and Drug Administration (FDA), on April 12, issued a Safety Communication recommending that consumers, healthcare providers, and facilities not use certain surgical N95 respirators and to use caution with certain surgical masks and pediatric face masks, all manufactured by O&M Halyard. The FDA says it is…

Read More

By: Judy Mathias
April 13, 2023
Share

Incidence of HAIs in hospitalized patients with, without COVID-19

Editor's Note This study from HCA Healthcare, Nashville, Tennessee, finds an increase in healthcare-associated infections (HAIs) in patients with COVID-19, but no increase in patients without COVID-19. More than 5 million hospitalizations in 182 hospitals between 2020 and 2022 were included in the analysis. The incidence of HAIs per 100,…

Read More

By: Judy Mathias
April 13, 2023
Share

SSI trends in community hospitals

Editor's Note In this study, researchers from the Duke Infection Control Outreach Network Surveillance Team, Duke University School of Medicine,  Durham, North Carolina, find that surgical site infection (SSI) rates did not decrease in community hospitals from 2013 to 2018. SSI data was collected from patients having 26 common surgical…

Read More

By: Judy Mathias
April 13, 2023
Share

FDA: Class I recall of Abbott’s glucose monitoring systems

Editor's Note The Food and Drug Administration (FDA), on April 6, identified the recall by Abbott of its FreeStyle Libre, FreeStyle Libre 14 day, and FreeStyle Libre 2 Flash Glucose Monitoring Systems as Class I, the most serious. The recall was initiated because the systems’ reader devices, which use rechargeable…

Read More

By: Judy Mathias
April 11, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat